With a market capitalization (market cap) of $2.71B — a measure of how much the company is worth — Regencell Bioscience Holdings Limited is the 1897th most valuable company in Healthcare as of August 18, 2026. Shares trade at $5.46, up +2.06% on the day.
of 2,587
price ÷ annual EPS
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
Regencell Bioscience Holdings Limited is a biotechnology firm specializing in Traditional Chinese Medicine (TCM). Its core activities revolve around the research, development, and market introduction of TCM solutions specifically designed to address neurocognitive disorders and related degeneration. The company places a particular emphasis on conditions such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Established in 2014, Regencell Bioscience maintains its primary office in Causeway Bay, Hong Kong.
Visit websiteAs of August 18, 2026, Regencell Bioscience Holdings Limited (RGC) is worth $2.71B — this is its market capitalization, the total value of all its outstanding shares.
Regencell Bioscience Holdings Limited’s market cap is $2.71B, which ranks it #1897 among the most valuable companies in the Healthcare sector tracked on MarketCapLens.
Regencell Bioscience Holdings Limited (RGC) shares trade at $5.46, up 2.06% on the day, as of August 18, 2026.
Fundamentals are annual. Figures labeled with their fiscal year.
FY 2025